High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr - MarketsandMarkets

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr - MarketsandMarkets
High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr
Published Feb 04, 2013
248 pages — Published Feb 04, 2013
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:

'Technological Advancements and Flourishing Outsourcing Industry Likely to Propel the Growth of the Global High Throughput Screening (HTS) Market'

In this report, the global high throughput screening (HTS) market has been segmented on the basis of technology, products, applications, end users, and geography. The label-free technology market is expected to grow at the highest CAGR of 11.1% from 2013 to 2018. This technology offers the direct detection ability, which was not possible with cell-based assays. Moreover, this technology helps in the reduction of drug failure rate due to toxicity and is applicable for a majority of drug classes.

In the HTS applications market, the target identification segment accounted for the largest share in 2013. The large share of this segment can be attributed to factors such as the availability of large compound libraries, presence of well-equipped HTS laboratories, and technological advancements. Large pharmaceutical and biotechnology companies are investing heavily in automation of HTS laboratories and are also entering into strategic partnerships and collaborations with research institutes, thereby leading to efficient utilization of HTS in varied application fields. However, the primary screening segment of the HTS market is estimated to register the highest growth rate. This can be attributed to the availability of a large number of potential lead compounds, emergence of several new detection technologies, and availability of novel primary and stem cell phenotypes. The HTS market by end users is broadly categorized into pharmaceutical companies, biotechnology companies, academic and government institutes, contract research organizations (CROs), and others. The pharmaceuticals segment dominated the market with a market share of around 48% in 2013.

The global HTS market is in its growth phase and is poised to cross the $19 billion mark by 2018. The factors responsible for the growth of this market include technological innovations, open innovation models adopted by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in the HTS technology by organizations. Moreover, the presence of a large untapped market in emerging countries and growth in outsourcing of drug discovery services especially in China and India are the various growth opportunities for this market.

Over the next five years, Asia is expected to grow at the highest CAGR of 9.1%. Factors such as growth in investments as well as the growth in the outsourcing industry, and favorable economic conditions are responsible for the high growth of the HTS market in Asia.

This research report covers a detailed analysis of various aspects of the HTS market, including the views on emerging and high-growth segments of HTS, emerging technologies, and high-growth regions. The report also discusses the drivers, restraints, opportunities, and the competitive landscape including key players in the HTS market along with their product portfolios, developments, and the strategies adopted by these players to maintain and grow their market shares in the near future. The above mentioned market research data, current market size, and the forecast of future trends will help established players and new entrants to make the necessary strategic decisions regarding investments in product development and market development and/or diversification. This data would also help companies to plan their product offerings, geographic focus, strategic approach, and R&D investments for innovation in their products and technologies and levels of output, in order to gain a competitive edge.

  
Source:
Document ID
BT 2220
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
Table Of Contents

1 Introduction (Page No. - 19)
1.1 Objectives of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Secondary Sources
1.6.2 Primary Sources
1.6.3 Market Size Estimation
1.6.4 Market Share
1.6.5 Key Data Points From Secondary Sources
1.6.6 Key Data Points From Primary Sources
1.6.7 Assumptions

2 Executive Summary (Page No. - 36)

3 Premium Insights (Page No. - 40)
3.1 HTS Market - A Sub-Segment of Drug Discovery Market
3.2 Global HTS Market
3.3 Market Dynamics
3.4 Geographic Analysis & HTS Technologies Market
3.5 Technology Market
3.6 End-User Analysis
3.7 Competitive Analysis

4 Market Overview (Page No. - 47)
4.1 Introduction
4.2 Technology Evolution
4.3 Market Segmentation
4.4 Market Dynamics
4.4.1 Drivers
4.4.1.1 Adoption of Open Innovation Models By Pharmaceutical Companies to Increase The Use of HTS
4.4.1.2 Increasing Drug Discovery Initiatives By Academic and Government Institutions to Boost The Demand for HTS Products
4.4.1.3 Increasing Capital Investments in HTS Technology By Organizations Lead to The Growth of HTS
4.4.1.4 Technological Advancements in Research Leading to Large Potential Candidates for Screening Will Help HTS
4.4.1.5 Increase in The Number of Outsourced Drug Discovery Services Will Propel The HTS Market
4.4.2 Restraints
4.4.2.1 The Capital-Intensive Nature of HTS Will Hamper The Growth of This Market
4.4.2.2 Assay Development for HTS Becoming Difficult for New Target Classes
4.4.3 Opportunities
4.4.3.1 Growing Asian Market to Boost The HTS Market
4.4.3.2 High Throughput Cellular Microarrays Increasingly Being Used in toxicology and Stem Cell Research, Thus Prompting Its Growth
4.4.3.3 Growth of Contract Research Organizations (Cros) in Emerging Countries to Bolster The HTS Market
4.4.3.4 Label-Free Technology Emerging As A Valuable Tool for Drug Discovery
4.5 Trends
4.5.1 Label-Free Method Gaining Importance in HTS Labs
4.5.2 HTS Techniques Increasingly Being Used in The Field of Toxicology
4.5.3 Automation & Miniaturization of HTS Techniques
4.6 Strategic Benchmarking
4.6.1 New Product Launches
4.6.1.1 Agilent Technologies Introduced The Rapidfire 365 High Throughput Mass Spectrometry System
4.6.1.2 Perkinelmer Introduced The Janus Biotx Pro Automated Workstation
4.6.1.3 Beckman Coulter Introduced The Navios Flow Cytometry System
4.6.1.4 Sigma-Aldrich Introduced The Compozr Transporter Knockout Human Cell Lines in Plate format
4.6.1.5 Tecan Group Introduced Dako Omnis
4.6.2 Technology Integration
4.6.2.1 Collaboration Between Agilent & Baylor College of Medicine's Medical Genetics Laboratories
4.6.2.2 Collaboration Between Perkinelmer & The National Center for Drug Screening (Ncds)
4.6.2.3 Partnership of Beckman Coulter With Illumina
4.6.2.4 Agreement of Sigma-Aldrich Corporation With Alphagenix
4.6.2.5 Agreement of Tecan Group With Tap Biosystems
4.7 Value Chain Analysis
4.8 Porter's Five Forces Analysis
4.8.1 Threat From New Entrants
4.8.2 Threat From Substitutes
4.8.3 Bargaining Power of Buyers
4.8.4 Bargaining Power of Suppliers

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr" Feb 04, 2013. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/High-Throughput-Screening-HTS-Market-by-Technology-Cell-Based-Ultra-High-Throughput-Screening-uHTS-Label-Free-Bioinformatics-by-Apllications-Target-Identification-Primary-Screening-Toxicology-Stem-Cell-by-End-Users-Pharmaceutical-Industr-2144-520>
  
APA:
MarketsandMarkets. (2013). High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr Feb 04, 2013. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/High-Throughput-Screening-HTS-Market-by-Technology-Cell-Based-Ultra-High-Throughput-Screening-uHTS-Label-Free-Bioinformatics-by-Apllications-Target-Identification-Primary-Screening-Toxicology-Stem-Cell-by-End-Users-Pharmaceutical-Industr-2144-520>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.